Arlington, Va. – The American Association of Colleges of Pharmacy has joined the RAPID Alliance Medications 360 Study to create a strategic roadmap and actionable next steps for optimizing use of medications, vaccines and related therapies for U.S. populations.
Launched by the University of Louisville Center for Health Organization Transformation (CHOT), a National Science Foundation-funded research center, the Frazier Polypharmacy Program at UofL, and the RAPID Alliance Research Consortium, the study builds on research conducted in 2020 during the COVID-19 pandemic that identified strategic opportunities to improve health and wellbeing for the U.S. population while reducing spending on likely-avoidable hospitalizations, emergency department and doctor visits by as much as $528 billion by optimizing medications and vaccine use.
Pharmacists are amongst 11 stakeholder groups invited to participate in the study, which calls for balanced representation from across the U.S. medication use ecosystem. There are multiple paths for deans, faculty and students to participate in the study. Senior leaders may register to join the study as voting participants in study panels, while faculty and students can register to join the study as panel facilitators, co-investigators or research assistants. More information is available here.